ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
1,2,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
1,3,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
3,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
6,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
7,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
8,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
9,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
10,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
11,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11,2,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
11,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
12,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
13,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
13,2,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
14,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
14,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
15,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
15,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
16,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
16,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
18,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
19,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
20,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
20,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
21,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
22,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
23,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
24,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
25,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
26,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
27,1,Acne,Acnes,Skin appendage conditions,Skin,N
28,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
29,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
30,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
31,1,Hepatic adenoma,Hepatobiliary neoplasms benign,Hepatic and biliary neoplasms benign,Neopl,N
31,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
32,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
32,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
33,1,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
33,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
33,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
33,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
34,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,Y
35,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
36,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
36,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
36,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
36,4,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
37,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
38,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
39,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
40,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
42,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
43,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
44,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
45,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
45,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
46,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
46,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
47,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
47,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
48,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
48,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
48,3,Headache,Headaches NEC,Headaches,Nerv,N
48,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
48,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
48,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
48,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
48,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
48,9,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
49,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
49,2,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
50,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
50,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
50,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
50,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
50,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
51,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
52,1,Engraft failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
52,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
52,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,4,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
53,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
53,2,Engraft failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
53,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
53,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
55,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
55,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
55,3,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
56,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
57,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
57,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
57,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
57,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
